Found 176 matching trials
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
PHASE2This study will evaluate the efficacy and safety of intravenous RC48-ADC co...
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
PHASE3This is a multicenter, randomized controlled, phase III clinical trial. The...
Location
Sun Yat-sen University Cancer Center
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
PHASE1This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
PHASE1This study is an open-label, dose-escalation and expansion, Phase I clinica...
Status
Active Not Recruiting
Location
St Vincent's Hospital Sydney
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer
PHASE2The purpose of this study is to evaluate the efficacy and safety of Disitam...
Location
Fudan University Shanghai Cancer Center
JS001+IMP4297 in Patients With Advanced Cancer
PHASE1This is a Phase I/Ib open-label, multicenter study to evaluate the safety, ...
Location
Multiple Locations
Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma
PHASE2This study is designed as Phase II/III. Phase II is aimed to evaluate safet...
Location
Beijing Cancer Hospital
Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors
PHASE1An ascending dose study in patients with solid tumors to evaluate the safet...
Location
Foshan First People's Hospital
Toripalimab With Chemotherapy for Sinus Cancer
PHASE2The aim of this research study is to evaluate the effectiveness and safety ...
Location
Brigham and Women's Hospital
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
PHASE4This study aims to investigate toripalimab with chemotherapy in participant...
Location
University of Arkansas for Medical Sciences